(Q62054015)

English

Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Efectividad de Saccharomyces Oulardii Para Reducir Los síntomas Gastrointestinales y Evitar el Sobrecrecimiento Bacteriano en Esclerosis sistémica (English)

0 references

0 references

0 references

June 2015

0 references

end time

December 2018

0 references

number of participants

45

0 references

research intervention

metronidazole

0 references

clinical trial phase

phase IV clinical trial

0 references

research subject recruitment status

completed

0 references

minimum age

18 year

0 references

maximum age

65 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03692299

0 references

(Q62054015)

Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)